CD4 and Alzheimer disease: Apparently, the exposure to β-amyloid peptides seems to play the role in these different results obtained for AD cells, especially the numbers of divisions, proliferation index and the G0→ G1 time; interestingly, the CD4+ cells of AD patients seem to react to the peptides more than these of healthy ones, suggesting possible role of different genetic background (the HLA)?